UPMC to buy majority stock in medCPU, lead $35 million round of funding

Posted on 03/02/2016

Compelled to improve patient outcomes and reduce cost through real-time clinical decision support (CDS), medCPU secures $35 million in new capital. The funding, led by new strategic partner UPMC, will support the expansion of the company and plans to co-innovate alongside medCPU to expand innovative decision support technology. With the overarching goal to improve patient outcomes and supply today’s clinicians and patients with valuable technological solutions, this strategic partnership acknowledges the growing healthcare decision support market.
Read more at:
UPMC Enterprises

Read more at:
Becker’s Hospital Review
Digital Journal
Healthcare Informatics
Healthcare IT News
HIStalk – 2/29
HIStalk – morning headline 3/1
HIT Consultant
MedCity News
Pittsburgh Business Times
Pittsburgh Post-Gazette
Private Equity & Venture Capital
Technology News
Thomson Reuters